Results 61 to 70 of about 27,854 (272)
Background: Alzheimer’s disease is a multifactorial neurodegenerative disorder. Current synthetic inhibitors often fail to address its complexity. Natural multitarget agents like Moringa oleifera and Curcuma longa may offer safer alternatives. Objective:
Shakira, Meutia Maulina
doaj +1 more source
Nutritional Interventions in Cancer Cachexia: Evidence and Perspectives From Experimental Models
Cancer cachexia is a complex metabolic syndrome characterized by involuntary skeletal muscle loss and is associated with poor clinical outcome, decreased survival and negatively influences cancer therapy.
Wouter R. P. H. van de Worp +5 more
doaj +1 more source
The complex network of malfunctioning pathways occurring in the pathogenesis of neurodegenerative diseases (NDDs) represents a huge hurdle in the development of new effective drugs to be used in therapy.
Andrea Bacci +3 more
doaj +1 more source
This study generates the single‐cell atlas of pathogenic B‐cell subset Bc‐5 in ITP. It identifies RUNX3 as a key survival regulator and uncovers sphingolipid‐driven metabolic reprogramming, validating UGCG inhibition as a therapeutic candidate and building a valuable resource for ITP mechanistic and therapeutic exploration.
Dongmei Luo +10 more
wiley +1 more source
Background/Objectives: The study investigated the anti-inflammatory potential of neolignan derivatives of dehydrodieugenol (CP1–CP5), focusing on the inhibition of secretory phospholipase A2 (sPLA2), a key enzyme in inflammation.
Adeilso B. Santos Junior +10 more
doaj +1 more source
This berberine‐loaded dual‐dynamically crosslinked nanogel integrates tannic acid‐zinc metal‐phenolic networks and carboxymethyl chitosan/aldehyde‐functionalized poly(ethylene glycol) dynamic Schiff base networks, achieving 1‐year colloidal and antioxidant stability, sustained corneal berberine exposure for 24 h to support convenient once‐daily dosing,
Yanru Xin +7 more
wiley +1 more source
Designing Approaches to Multitarget Drugs
Plexxikon adopted a fragment-based drug discovery strategy for the design of multitarget drugs that represents an evolution of the procedure followed for the discovery of a family of selective phosphodiesterase (PDE) inhibitors.
Luca Costantino +3 more
core +1 more source
Dual Targeting Strategies in Cancer: Carbonic Anhydrase IX Inhibitors Targeting EGFR or VEGFR-2
Tumor microenvironment influences the process of tumorigenesis, with hypoxia being a characteristic of many solid tumors and an adverse prognostic factor.
Eleftherios Charissopoulos +1 more
doaj +1 more source
Artificial intelligence is redefining network pharmacology (NP). By integrating knowledge graph engineering, geometric deep learning, multiomics anchoring, and generative reasoning, AI‐driven NP (AI‐NP) transforms static target mapping into dynamic, predictive modeling.
Cong Wang +9 more
wiley +1 more source
Engineering Biology Beyond Single Genes: Advances and Challenges in Multiplex Genome Editing
Multiplex genome editing is transforming genome engineering from single‐gene perturbation to network‐level control, yet its broader application remains limited by challenges in gRNA array engineering, delivery technologies, and safety management. Emerging AI‐driven approaches are accelerating guide RNA design and CRISPR effector optimization for ...
Linli Wang, Yongbin Liu, Hongbing Han
wiley +1 more source

